• Something wrong with this record ?

Liquid antisolvent crystallization of pharmaceutical compounds: current status and future perspectives

R. Kumar, AK. Thakur, N. Banerjee, A. Kumar, GK. Gaurav, RK. Arya

. 2023 ; 13 (2) : 400-418. [pub] 20220811

Language English Country United States

Document type Journal Article, Review

The present work reviews the liquid antisolvent crystallization (LASC) to prepare the nanoparticle of pharmaceutical compounds to enhance their solubility, dissolution rate, and bioavailability. The application of ultrasound and additives is discussed to prepare the particles with narrow size distribution. The use of ionic liquid as an alternative to conventional organic solvent is presented. Herbal compounds, also known for low aqueous solubility and limited clinical application, have been crystalized by LASC and discussed here. The particle characteristics such as particle size and particle size distribution are interpreted in terms of supersaturation, nucleation, and growth phenomena. To overcome the disadvantage of batch crystallization, the scientific literature on continuous flow reactors is also reviewed. LASC in a microfluidic device is emerging as a promising technique. The different design of the microfluidic device and their application in LASC are discussed. The combination of the LASC technique with traditional techniques such as high-pressure homogenization and spray drying is presented. A comparison of product characteristics prepared by LASC and the supercritical CO2 antisolvent method is discussed to show that LASC is an attractive and inexpensive alternative for nanoparticle preparation. One of the major strengths of this paper is a discussion on less-explored applications of LASC in pharmaceutical research to attract the attention of future researchers.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22031977
003      
CZ-PrNML
005      
20230131151815.0
007      
ta
008      
230120s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s13346-022-01219-1 $2 doi
035    __
$a (PubMed)35953765
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kumar, Rahul $u Department of Chemical Engineering, Energy Cluster, University of Petroleum and Energy Studies, Dehradun, 248007, Uttarakhand, India. rahul.iitrahul@gmail.com $1 https://orcid.org/0000000159943749
245    10
$a Liquid antisolvent crystallization of pharmaceutical compounds: current status and future perspectives / $c R. Kumar, AK. Thakur, N. Banerjee, A. Kumar, GK. Gaurav, RK. Arya
520    9_
$a The present work reviews the liquid antisolvent crystallization (LASC) to prepare the nanoparticle of pharmaceutical compounds to enhance their solubility, dissolution rate, and bioavailability. The application of ultrasound and additives is discussed to prepare the particles with narrow size distribution. The use of ionic liquid as an alternative to conventional organic solvent is presented. Herbal compounds, also known for low aqueous solubility and limited clinical application, have been crystalized by LASC and discussed here. The particle characteristics such as particle size and particle size distribution are interpreted in terms of supersaturation, nucleation, and growth phenomena. To overcome the disadvantage of batch crystallization, the scientific literature on continuous flow reactors is also reviewed. LASC in a microfluidic device is emerging as a promising technique. The different design of the microfluidic device and their application in LASC are discussed. The combination of the LASC technique with traditional techniques such as high-pressure homogenization and spray drying is presented. A comparison of product characteristics prepared by LASC and the supercritical CO2 antisolvent method is discussed to show that LASC is an attractive and inexpensive alternative for nanoparticle preparation. One of the major strengths of this paper is a discussion on less-explored applications of LASC in pharmaceutical research to attract the attention of future researchers.
650    _2
$a krystalizace $x metody $7 D003460
650    _2
$a rozpouštědla $x chemie $7 D012997
650    12
$a voda $7 D014867
650    12
$a nanočástice $x chemie $7 D053758
650    _2
$a léčivé přípravky $7 D004364
650    _2
$a velikost částic $7 D010316
650    _2
$a rozpustnost $7 D012995
650    _2
$a farmaceutická technologie $7 D013678
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Thakur, Amit K $u Department of Chemical Engineering, Energy Cluster, University of Petroleum and Energy Studies, Dehradun, 248007, Uttarakhand, India
700    1_
$a Banerjee, Nilanjana $u Department of Chemical Engineering, Energy Cluster, University of Petroleum and Energy Studies, Dehradun, 248007, Uttarakhand, India
700    1_
$a Kumar, Ashutosh $u Department of Chemical Engineering, Indian Institute of Technology Delhi, 110016, New Delhi, India
700    1_
$a Gaurav, Gajendra Kumar $u Sustainable Process Integration Laboratory, SPIL, NETME Centre, Faculty of Mechanical Engineering, Brno University of Technology, VUT Brno, Technická 2896/2, 616 69, Brno, Czech Republic
700    1_
$a Arya, Raj Kumar $u Department of Chemical Engineering, Dr. B.R. Ambedkar National Institute of Technology, Jalandhar, India
773    0_
$w MED00197253 $t Drug delivery and translational research $x 2190-3948 $g Roč. 13, č. 2 (2023), s. 400-418
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35953765 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151811 $b ABA008
999    __
$a ok $b bmc $g 1891019 $s 1183312
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 13 $c 2 $d 400-418 $e 20220811 $i 2190-3948 $m Drug delivery and translational research $n Drug Deliv Transl Res $x MED00197253
LZP    __
$a Pubmed-20230120

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...